Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug.
Feb 23 (Reuters) - Eli Lilly said on Monday it received the U.S. Food and Drug Administration's approval to launch a four-dose KwikPen for its weight-loss drug Zepbound, delivering a full month of the ...